Shockwave Medical

CA - Santa ClaraBiotechnology4 H-1B visas (FY2023)

Focus: Shockwave Medical is a medical device company specializing in intravascular lithotripsy (IVL) technology for treating calcified vascular lesions across coronary, peripheral, and structural heart applications. Founded in 2017 and headquartered in Santa Clara, CA, the company operates in the high-growth cardiovascular device space.

Cardiovascular

Profile data last refreshed 4h ago · AI intelligence enriched 1w ago

Open Jobs

Should You Work at Shockwave Medical?

AI assessment

Shockwave Medical offers medical device stability and platform upside for specialists in cardiovascular/device development, but exceptionally tight hiring suggests you need specialized expertise or insider connections to break in.

Why Work Here

Proprietary platform technology (lithoplasty) with broad applicability across multiple vascular indications and expanding clinical pipeline

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

44 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

IVL with Shockwave C2+ 2Hz Coronary IVL Catheter

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT05966662Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

N/A

Help build intelligence for Shockwave Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Strong IP trajectory demonstrated by 30+ distinct pipeline programs across coronary, peripheral, and structural heart markets with active clinical trials

Medical device company with recurring revenue model, offering stability compared to earlier-stage biotech while maintaining innovation upside

Watch Out For

Extremely limited hiring visibility: only 1 active job posting across the entire company signals contraction or highly selective recruitment
Heavy dependence on single technology platform (IVL/lithoplasty) creates concentration risk if clinical or reimbursement headwinds emerge

Generated by Claude from Shockwave Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Shockwave Medical Mini S Peripheral IVL Catheter

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05058456Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

N/A

DISRUPT PAD III Observational Study

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05881421DISRUPT PAD III Observational Study

N/A

Shockwave Lithoplasty® Peripheral Lithoplasty System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT02923193Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)

N/A

Shockwave Lithoplasty System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT02369848Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)

N/A

Intravascular Lithotripsy

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05858905FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter

N/A

Shockwave Lithoplasty System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT02071108Safety and Performance Study of the Shockwave Lithoplasty System

N/A

Shockwave Medical M5+ Peripheral Intravascular Lithotripsy

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT04585763Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System

N/A

Shockwave Lithoplasty® System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT02911623Safety and Feasibility of the Shockwave Lithoplasty® System for the Treatment of Peripheral Vascular Stenosis

N/A

Intravascular Lithotripsy

Peripheral Artery Disease

N/A

Clinical Trials (1)

NCT05007925Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

N/A

Intravascular Lithotripsy

PAD - Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT07130526Distrupt Stiffness Trial

N/A

Shockwave Intravenous lithotripsy with a Supera stent

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05147363Shockwave: Disruption for A Better Fit

N/A

TIARA valve and transapical delivery system

Mitral Valve Regurgitation

N/A

Clinical Trials (1)

NCT03039855Tiara™ Transcatheter Mitral Valve Replacement Study

N/A

PCI with use of IVL

Calcific Coronary Arteriosclerosis

N/A

Clinical Trials (1)

NCT06577038Prospective Registry on Intravascular Lithotripsy

N/A

Intravascular Lithotripsy

Coronary Arterial Disease (CAD)

N/A

Clinical Trials (1)

NCT06662500FORWARD CAD IDE Study

N/A

Shockwave System Treatment

Vascular Disease

N/A

Clinical Trials (1)

NCT01577888Safety and Feasibility Study of the Shockwave Lithoplasty System

N/A

IVL procedures

Coronary Disease

N/A

Left main stenting with intravascular lithotripsy

Coronary Artery Calcification

N/A

Clinical Trials (1)

NCT04319666Intravascular Balloon Lithotripsy in Left Main Stem Percutaneous Coronary Intervention

N/A

Carotid Intravascular Lithotripsy

Carotid Artery Calcification

N/A

Shockwave

Vascular Diseases

N/A

Clinical Trials (1)

NCT04600934Shockwave Assisted Large Bore Access

N/A

Shockwave Balloon

Iliac Disease

N/A

Clinical Trials (1)

NCT05862558Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR

N/A

Shockwave M5 IVL Catheter

Aortic Stenosis

N/A

Clinical Trials (1)

NCT07205068Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure

N/A

Intravascular Lithotripsy

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT04960319Rotablation vs Intravascular Lithotripsy in Calcified Coronary Lesions

N/A

Peripheral Intravascular Lithotripsy

Peripheral Arterial Disease

N/A

Shockwave Coronary Lithoplasty System

Coronary Stenosis

N/A

Clinical Trials (1)

NCT02758379Shockwave Coronary Lithoplasty Study

N/A

Shockwave™ Peripheral Intravascular Lithotripsy Balloon M5+

Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture

N/A

Clinical Trials (1)

NCT06332911Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair

N/A

Shockwave Medical IVL System

Chronic Limb-Threatening Ischemia

N/A

Clinical Trials (1)

NCT06149650Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

N/A

Shockwave Intravascular Lithotripsy

Femoral Arterial Calcification

N/A

Clinical Trials (1)

NCT05145478CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

N/A

Mitral valve replacement

Mitral Valve Regurgitation

N/A

Clinical Trials (1)

NCT02276547Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

N/A

Coronary sinus reducer

Coronary Microvascular Disease

N/A

Clinical Trials (1)

NCT04606459COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

N/A

CT-guided PCI

Coronary Artery Disease

N/A

Lithotripsy

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT04151628Disrupt CAD IV With the Shockwave Coronary IVL System

N/A

Shockwave C2 Coronary IVL

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT05021757Disrupt CAD III Post-Approval Study (PAS)

N/A

Shockwave Medical Coronary IVL System

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT05755711Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

N/A

IVL Coronary Lithotripsy System

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT03328949Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)

N/A

Arm 1: treatment with Shockwave Reducer

Refractory Angina

N/A

Clinical Trials (1)

NCT05102019Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

N/A

Shockwave Coronary Rx Lithoplasty® System

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT02650128Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I)

N/A

Coronary Sinus Reducer

Heart Failure Preserved Ejection Fraction

N/A

Clinical Trials (1)

NCT07057323Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure

N/A

Lithotripsy

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT03595176Disrupt CAD III With the Shockwave Coronary IVL System

N/A

Reducer System

Angina Pectoris

N/A

Clinical Trials (1)

NCT02710435REDUCER-I: An Observational Study of the Neovasc Reducer™ System

N/A

Neovac coronary sinus reducer

Refractory Angina

N/A

Clinical Trials (1)

NCT01566175Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

N/A

Metricath Gemini System

Angioplasty

Phase 2

Clinical Trials (1)

NCT00399646Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations.

Phase 2

Neovasc Reducer

Refractory Angina

Phase 2

Clinical Trials (1)

NCT01205893Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA

Phase 2

Interview Prep Quick Facts

Founded: 2017

Portfolio: 39 clinical trials

Top TAs: Cardiovascular

H-1B (2023): 4 approvals

Open Roles: 1 active job

Therapeutic Area Focus

Cardiovascular

18 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Shockwave Medical

Should You Work at Shockwave Medical?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Open Jobs (1)

Project Manager

Hiring Trend

Visa Sponsorship